BAFNA PHARMACEUTICALS
Back to Balance Sheet
|
BAFNA PHARMACEUTICALS Last 5 Year Total Current Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹52 Cr | ₹54 Cr | ₹46 Cr | ₹22 Cr | ₹24 Cr |
What is the latest Total Current Liabilities ratio of BAFNA PHARMACEUTICALS ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹52 Cr |
| Mar2024 | ₹54 Cr |
| Mar2023 | ₹46 Cr |
| Mar2022 | ₹22 Cr |
| Mar2021 | ₹24 Cr |
How is Total Current Liabilities of BAFNA PHARMACEUTICALS Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹52 Cr | -4.13 | |
| Mar2024 | ₹54 Cr | 16.37 | |
| Mar2023 | ₹46 Cr | 111.13 | |
| Mar2022 | ₹22 Cr | -9.45 | |
| Mar2021 | ₹24 Cr | - | |
Compare Total Current Liabilities of peers of BAFNA PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BAFNA PHARMACEUTICALS | ₹677.6 Cr | 18% | 12.7% | 206% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,114.0 Cr | NA | -3.9% | 17.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹239,321.0 Cr | 5% | 21.5% | 44.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,924.0 Cr | -2.1% | -0.2% | 34.3% | Stock Analytics | |
| CIPLA | ₹113,778.0 Cr | -2% | -2.5% | -8.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,025.9 Cr | 0.4% | 4.5% | -4.4% | Stock Analytics | |
BAFNA PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BAFNA PHARMACEUTICALS | 18% |
12.7% |
206% |
| SENSEX | 0.7% |
0.8% |
-5.1% |
You may also like the below Video Courses